PulseAugur
EN
LIVE 14:50:47

Oncotype DX leads breast cancer recurrence risk prediction with gene expression assays

By PulseAugur Editorial · [1 sources] ·

The Oncotype DX test is a widely used gene expression assay that helps predict breast cancer recurrence risk and potential benefit from chemotherapy. It is part of a broader category of molecular recurrence scores, including MammaPrint, Prosigna, and EndoPredict, which aim to personalize treatment by integrating tumor biology. These scores are crucial for guiding treatment selection, maximizing therapeutic benefit, and minimizing unnecessary toxicity. AI

IMPACT Personalized treatment strategies for breast cancer are being enhanced by gene expression assays like Oncotype DX.

RANK_REASON The item discusses a gene expression assay for medical research and clinical application, not a frontier AI model release. [lever_c_demoted from research: ic=1 ai=0.4]

Read on Towards AI →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Oncotype DX leads breast cancer recurrence risk prediction with gene expression assays

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The item discusses a gene expression assay for medical research and clinical application, not a frontier AI model release. [lever_c_demoted from research: ic=1 ai=0.4]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, paper
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
59 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Towards AI TIER_1 English(EN) · Suryansh Shukla ·

    Recurrence Risk Prediction in Breast Cancer From Oncotype DX to Advanced Generative Models

    <figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*z9gWMatN_p1MYoQNapBj5A.png" /></figure><blockquote>Google docs version click <a href="https://docs.google.com/document/d/1FORBJgyq-ayMncokYMRSCV1sqTMXM7pg8kjQK1eT7pA/edit?usp=sharing">here</a></blockquote><h3>1. …

RELATED ENTITIES

RELATED TOPICS